Abbott Stock: Medical Giant Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott Stock: Medical Giant Shrugs Off ‘Middling’ Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott stock reversed early losses Wednesday, shrugging off a “middling” quarter, on its strong sales outlook for 2025 and a bullish fourth-quarter performance from its diabetes devices. ↑ X NOW PLAYING How To Buy Stocks: Profit From Earnings Reports Using This Option Strategy For the full year, Abbott Laboratories (ABT) expects sales to grow 7.5%…

Read More
Intuitive Surgical Stock Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts

Intuitive Surgical Stock Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts

Intuitive Surgical (ISRG) stock broke out Wednesday after the robotic surgery giant crushed Wall Street’s expectations in its preliminary fourth-quarter report. ↑ X NOW PLAYING How To Buy Stocks: Flat Base Chart Pattern During the December quarter, sales surged 25% to $2.41 billion, the company said. That easily beat forecasts for $2.2 billion, according to…

Read More
Palantir Refuses To Fall, Hits All-Time High

Palantir Refuses To Fall, Hits All-Time High

Artificial intelligence software maker Palantir Technologies (PLTR) hit another all-time high Friday despite the market’s pullback. It was the seventh new high for Palantir in the last nine trading sessions, and catapulted its stock into the Stock Spotlight list. Energy play Oneok (OKE) also high a fresh high and landed in the Stock Spotlight. Financial…

Read More
Intuitive Surgical Stock Adds To 40% Run With Massive Profit Beat, Strong Procedure Growth

Intuitive Surgical Stock Adds To 40% Run With Massive Profit Beat, Strong Procedure Growth

Intuitive Surgical (ISRG) stock surged late Thursday after the robotic surgery behemoth blasted third-quarter earnings expectations out of the water. ↑ X NOW PLAYING How To Buy Stocks: IBD’s Four Pillars Of Investing During the September quarter, Intuitive Surgical earned an adjusted $1.84 per share. That walloped forecasts for $1.64 a share and grew 26%…

Read More
10x Genomics Stock Crashes. 'Disruptive' Changes Hit Third-Quarter Sales

10x Genomics Stock Crashes. ‘Disruptive’ Changes Hit Third-Quarter Sales

10x Genomics (TXG) stock crashed Thursday after the medtech reported preliminary third-quarter sales that widely missed Street expectations, thanks to a highly “disruptive” reorganization. ↑ X NOW PLAYING How To Sell Stocks: Long-Term Trend Lines The company is a leader in spatial biology, a process that involves understanding where specific cells and tissues are within…

Read More